Azevan Pharmaceuticals' Series C Round

Azevan Pharmaceuticals raised a round of funding on October 18, 2013.

Azevan Pharmaceuticals is a clinical stage, small molecule drug development company developing novel therapeutics to treat disorders of stress, mood, and behavior. The Company's first clinical compoun…

Articles about Azevan Pharmaceuticals' Series C Round: